Keefe Bruyette reiterates Zions Bancorp stock rating at Market Perform

Keefe, Bruyette & Woods reiterated a Market Perform rating on Zions Bancorp and set a $75 price target, citing positive operating leverage and capital flexibility. The stock trades at 10.0x the 2027 earnings estimate and at a P/E of 8.68, which the article frames as undervaluation versus fair value, while 2027 ROTCE is projected at 13.2% vs 16.1% for peers. The note also references mixed post–Q2 adjustments from other analysts tied to net interest income guidance and very low credit costs that supported an EPS beat.

Analysis

ZION is trading like a balance-sheet cleanup story, but the market will only rerate it if management proves earnings power can compound faster than deposits reprice. The real upside is not the current earnings beat; it is whether tangible book can start compounding into a higher ROTCE band and justify a peer-like multiple. If that does not show up in the next 1-2 quarters, the stock remains an optically cheap regional bank with limited multiple expansion.

The main second-order effect is relative performance inside the regional bank complex: names with cleaner fee mix, better loan growth, or less NII sensitivity should absorb capital if investors rotate toward banks that can defend operating leverage. On the other hand, any renewed concern around deposit competition or CRE normalization would hit the whole small-bank basket, with ZION particularly exposed because the case depends on earnings quality improving faster than the cycle worsens.

The key catalyst path is the next earnings cycle and any Fed signal that changes the front-end rate path. A faster easing cycle helps funding costs, but if asset yields roll over more quickly, NII can still disappoint and overwhelm the credit narrative. The contrarian miss is that the market may be too focused on low loss provisions and not enough on how fragile the valuation bridge is without a visible NII inflection.

Trade-wise, this is better expressed as a relative-value position than an outright high-conviction long. If management reiterates operating leverage and no deterioration in core NII, ZION can outperform the sector basket over 1-3 months; if not, the valuation case likely stalls.

Key Decisions for Investors

• Long ZION / short KRE for 1-3 months into the next earnings cycle: use as a relative-value expression on bank-specific execution versus sector beta; thesis fails if core NII guidance is cut again.
• Do not chase an outright long in ZION until management confirms deposit costs are stable and ROTCE is trending toward the peer range; otherwise the stock is likely a value trap rather than a re-rating candidate.
• Set a watch item on the next earnings print: if ZION’s ROTCE still screens below ~13.5% or NII under-delivers versus consensus, fade strength and rotate to higher-quality regional banks such as TBBK or OZK.